Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank75
Studio
Year-over-Year Change

Research and development spending

Percentile
P75
Within normal range
vs 2Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$11.84M-61.8%
2024$31.03M+604.7%
2023$4.40M-
2022$0.00-100.0%
2021$2.96M-